AvenCell Funding: $362M Raised, Series B (2024)

AvenCell funding overview

AvenCell is based in Watertown, Massachusetts. AvenCell has raised $362M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in October 2024. The round record for AvenCell runs through 2024; nothing later has been disclosed. Investors on record include Blackstone Life Sciences, Novo Holdings, F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, NYBC Ventures. 6 distinct backers are named across the disclosed rounds.

AvenCell at a glance

Total raised: $362M
Latest round: Series B
Latest round date: October 2024
Headquarters: Watertown, Massachusetts
Notable investors: Blackstone Life Sciences, Novo Holdings, F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, NYBC Ventures

Frequently asked about AvenCell funding

How much has AvenCell raised?: AvenCell has raised $362M in total disclosed funding across the rounds on record.
Who has invested in AvenCell?: Blackstone Life Sciences, Novo Holdings, F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, NYBC Ventures are named among the investors backing AvenCell.
What was the latest AvenCell funding round?: The most recent disclosed round is a Series B, announced in October 2024.
Where is AvenCell based?: AvenCell is based in Watertown, Massachusetts.
When did AvenCell last raise?: The last disclosed AvenCell round closed in October 2024 at Series B.

AvenCell totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Watertown below to benchmark round size and investor mix.

AvenCell Funding: $362M Raised, Series B (2024)

AvenCell funding overview

AvenCell at a glance

Frequently asked about AvenCell funding

Companies related to AvenCell (23)

Browse related funding lists (4)